How do I decide between surgery and radiation for Stomach Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Deciding Between Surgery and Radiation for Stomach Cancer
This is an important decision that depends on several factors specific to your situation. Let me explain how doctors typically approach this choice, and then I'll outline questions you should discuss with your care team.
How Doctors Think About This Decision
According to NCCN Guidelines for Gastric Cancer, the choice between surgery and radiation (or combinations of treatments) depends primarily on:
- Whether your cancer can be surgically removed (resectable vs. unresectable)
- The stage and extent of your cancer (how deep it goes, whether lymph nodes are involved)
- Your overall health (whether you're medically fit for major surgery)
- Whether you've already received chemotherapy (neoadjuvant therapy before surgery)
General Treatment Approaches
Surgery as Primary Treatment
Surgery is typically the preferred approach for most stomach cancers that can be removed, because:
- It offers the best chance for cure in early-to-intermediate stages
- It removes the tumor and surrounding lymph nodes in one procedure
- According to NCCN Guidelines, surgery is appropriate for cancers that are T1b or deeper, or for actively bleeding cancers
The typical surgical approach includes:
- Removing part or all of the stomach
- Removing nearby lymph nodes (called D2 lymph node dissection)
- Reconstruction to allow normal eating afterward
Radiation Therapy
Radiation is typically used in these situations:
- Combined with chemotherapy (chemoradiation) after surgery if there are high-risk features
- As primary treatment if surgery isn't possible due to medical reasons or if the cancer is unresectable
- For palliative care (symptom relief) if cure isn't possible
According to NCCN Guidelines, fluoropyrimidine-based chemoradiation is a standard approach for patients who have had surgery and have certain risk factors.
Perioperative Systemic Therapy (Chemotherapy)
NCCN Guidelines emphasize that chemotherapy before and/or after surgery is a Category 1 recommendation (highest priority) for most patients with resectable gastric cancer. This means:
- Chemotherapy often comes BEFORE surgery to shrink the tumor
- Surgery follows to remove what remains
- Additional chemotherapy or chemoradiation may follow surgery
Special note: If your tumor is MSI-H or dMMR (specific genetic markers), immunotherapy may be considered as part of your perioperative treatment plan.
Key Factors Your Doctor Will Consider
| Factor | What It Means | |--------|---------------| | Tumor depth (T-stage) | How far the cancer has invaded the stomach wall | | Lymph node involvement (N-stage) | Whether cancer has spread to nearby lymph nodes | | Distant spread (M-stage) | Whether cancer has spread to distant organs | | Your fitness for surgery | Your heart, lung, and overall health status | | Tumor location | Where in the stomach the cancer is located | | Biomarkers | MSI-H/dMMR status, HER2 status, and other genetic features |
Questions to Ask Your Oncology Team
-
"Is my cancer resectable (can it be surgically removed)? If not, why not?"
- This fundamentally changes your treatment options
-
"What is my complete staging (TNM stage), and what does that mean for my prognosis?"
- Understanding your stage helps you understand why certain treatments are recommended
-
"Will I receive chemotherapy before surgery, after surgery, or both?"
- NCCN Guidelines recommend perioperative chemotherapy for most patients
-
"Have my tumor biomarkers been tested (MSI-H/dMMR, HER2, etc.)?"
- These results may open up additional treatment options like immunotherapy
-
"If surgery is recommended, what type of surgery would I have, and what are the risks and benefits?"
- Different surgical approaches have different outcomes and side effects
-
"If I'm not a surgical candidate, what are my radiation and chemotherapy options?"
- Understanding alternatives is important if surgery isn't possible
-
"What is the goal of treatment—cure or symptom management?"
- This changes the entire treatment approach and helps set realistic expectations
-
"What side effects should I expect from each option, and how will they affect my quality of life?"
- Both surgery and radiation have different recovery periods and potential complications
-
"How experienced is your team with gastric cancer surgery?"
- Specialized centers often have better outcomes
-
"Can I get a second opinion from another gastric cancer specialist?"
- This is always reasonable for a major cancer decision
Important Context
According to NCCN Guidelines, the standard approach for most medically fit patients with resectable gastric cancer is:
Perioperative systemic therapy (chemotherapy) → Surgery → Possible additional chemotherapy or chemoradiation
This multimodal approach (combining multiple treatments) has been shown to improve outcomes compared to surgery alone.
However, YOUR specific situation requires your doctor's evaluation of your complete clinical picture, including your imaging studies, pathology results, biomarkers, and overall health status.
Bottom Line
The choice between surgery and radiation isn't really "either/or" for most gastric cancer patients—it's usually "both, in a specific sequence." Your oncology team will determine the most appropriate approach for YOUR case based on your staging, biomarkers, and medical fitness.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Gastric Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Stomach Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: